GSK & MMV announce first single-dose medicine for P. vivax malaria, tafenoquine prequalified by WHO and included in WHO ...
GSK plc and Medicines for Malaria Venture (MMV) announced that the World Health Organization (WHO) has awarded prequalification to tafenoquine, the first single-dose medicine for the prevention of relapse of?Plasmodium vivax?(P. vivax) malaria. Tafenoquine …